Mario Regazzi

5.1k total citations
136 papers, 3.6k citations indexed

About

Mario Regazzi is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Mario Regazzi has authored 136 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Infectious Diseases, 29 papers in Epidemiology and 27 papers in Virology. Recurrent topics in Mario Regazzi's work include HIV/AIDS drug development and treatment (37 papers), HIV Research and Treatment (27 papers) and Pneumocystis jirovecii pneumonia detection and treatment (17 papers). Mario Regazzi is often cited by papers focused on HIV/AIDS drug development and treatment (37 papers), HIV Research and Treatment (27 papers) and Pneumocystis jirovecii pneumonia detection and treatment (17 papers). Mario Regazzi collaborates with scholars based in Italy, United States and Canada. Mario Regazzi's co-authors include P. Villani, Maria Cusato, I. Buggia, I Iacona, Carlo Campana, Mariadelfina Molinaro, Roberto Imberti, Giorgio Antonio Iotti, Massimo Allegri and Manuela De Gregori and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of the American College of Cardiology.

In The Last Decade

Mario Regazzi

134 papers receiving 3.5k citations

Peers

Countries citing papers authored by Mario Regazzi

Since Specialization

Citations

This map shows the geographic impact of Mario Regazzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Regazzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Regazzi more than expected).

Fields of papers citing papers by Mario Regazzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Regazzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Regazzi. The network helps show where Mario Regazzi may publish in the future.

Co-authorship network of co-authors of Mario Regazzi

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Regazzi. A scholar is included among the top collaborators of Mario Regazzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Regazzi. Mario Regazzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Comparison of Differences Between the Systemic Pharmacokinetics of Levobupivacaine and Ropivacaine During Continuous Epidural Infusion 2015 ·Anesthesia & Analgesia ·Luciano Perotti, Maria Cusato, Pablo Ingelmo, (unknown), Marta Somaini, Francesca Riva, Carmine Tinelli, José De Andrés, Gregory C. Fanelli, Antonio Braschi, Mario Regazzi, Massimo Allegri	12
2	Systemic exposure to rifampicin in patients with tuberculosis and advanced HIV disease during highly active antiretroviral therapy in Burkina Faso 2011 ·Journal of Antimicrobial Chemotherapy ·Nuccia Saleri, (unknown), P. Villani, Anna Cristina Calçada Carvalho, Maria Cusato, (unknown), (unknown), Séni Kouanda, Mario Comelli, Mario Regazzi, Alberto Matteelli	12
3	Pharmacogenetics and postoperative pain: a new approach to improve acute pain management. 2010 ·PubMed ·Massimo Allegri, Manuela De Gregori, (unknown), Cristina E. Minella, Carmine Tinelli, Stefano Govoni, Mario Regazzi, Antonio Braschi	19
4	Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations 2009 ·Journal of Cardiovascular Medicine ·Fabiana Isabella Gambarin, Valentina Favalli, Alessandra Serio, Mario Regazzi, Michele Pasotti, Catherine Klersy, Roberto Dore, Savina Mannarino, Mario Viganò, Attilio Odero, (unknown), Luigi Tavazzi, Eloisa Arbustini	53
5	Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura 2008 ·Haematologica ·Francesco Zaja, Marta Lisa Battista, (unknown), (unknown), Marco Montagna, Nicola Vianelli, (unknown), M. Cavallin, Monica Bocchia, Marzia Defina, M. Ippoliti, Felicetto Ferrara, Francesca Patriarca, Maria Antonietta Avanzini, Mario Regazzi, Michele Baccarani, Miriam Isola, Franca Soldano, Renato Fanin	78
6	Atazanavir and lopinavir with ritonavir alone or in combination: analysis of pharmacokinetic interaction and predictors of drug exposure 2008 ·HIV Medicine ·Simona Di Giambenedetto, Andrea De Luca, P. Villani, (unknown), Enzo Ragazzoni∘, Mario Regazzi, Roberto Cauda, Pierluigi Navarra	14
7	Alemtuzumab As Consolidation After a Response to Fludarabine Is Effective in Purging Residual Disease in Patients With Chronic Lymphocytic Leukemia 2006 ·Journal of Clinical Oncology ·Marco Montillo, Alessandra Tedeschi, Sara Miqueleiz, Silvio Veronese, Roberto Cairoli, (unknown), Francesca Ricci, (unknown), Barbara Scarpati, Michela Montagna, Michele Nichelatti, Mario Regazzi, Enrica Morra	111
8	A “Steroid-Free” Tacrolimus and Low-Dose Mycophenolate Mofetil Primary Immunosuppression Does Not Prevent Early Acute Rejection After Liver Transplantation 2005 ·Transplantation Proceedings ·P. Reggiani, Marcella Arru, Mario Regazzi, Stefano Gatti, Mariadelfina Molinaro, L. Caccamo, U. Maggi, (unknown), (unknown), G. Rossi	16
9	Steady-state pharmacokinetics of atazanavir given alone or in combination with saquinavir hard-gel capsules or amprenavir in HIV-1-infected patients 2005 ·European Journal of Clinical Pharmacology ·Elena Seminari, Monica Guffanti, P. Villani, Nicola Gianotti, Maria Cusato, (unknown), Andrea Galli, Antonella Castagna, Mario Regazzi, Adriano Lazzarin	12
10	Immunochemotherapy with Rituximab, Vincristine and 5-Day Cyclophosphamide for Heavily Pretreated Follicular Lymphoma 2005 ·Oncology ·Mario Lazzarino, Luca Arcaini, Ester Orlandi, I Iacona, Paolo Bernasconi, Silvia Calatroni, Marzia Varettoni, (unknown), Ercole Brusamolino, Maurizio Bonfichi, Francesco Passamonti, Sara Burcheri, Cristiana Pascutto, Mario Regazzi	7
11	Prediction of early and confirmed virological response by genotypic inhibitory quotients for lopinavir in patients naïve for lopinavir with limited exposure to previous protease inhibitors 2005 ·Journal of Clinical Virology ·Carlo Torti, Maria Cristina Uccelli, Eugenia Quirós-Roldán, Franco Gargiulo, (unknown), Giuseppe Lapadula, Mario Regazzi, Piera Pierotti, Carmine Tinelli, Andrea De Luca	8
12	Pharmacokinetic study of intraarterial local intestinal infusion of tacrolimus 2000 ·Transplantation Proceedings ·M Alessiani, Mario Regazzi, (unknown), Paola Ferrari, (unknown), I Iacona, Catherine Klersy, (unknown), (unknown), Antonello Pileggi, (unknown), Barbara Burroni, (unknown), Paolo Dionigi, A. Zonta	2
13	Efavirenz, Nelfinavir, and Stavudine Rescue Combination Therapy in HIV-1–Positive Patients Heavily Pretreated With Nucleoside Analogues and Protease Inhibitors 1999 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Elena Seminari, Franco Maggiolo, P. Villani, Fredy Suter, Angelo Pan, Mario Regazzi, Carmine Tinelli, Renato Maserati	21
14	Tacrolimus and mycophenolate mofetil in pig small bowel transplantation: Different protocols and their outcome 1997 ·Transplantation Proceedings ·Marco Spada, M Alessiani, Paolo Ferrari, I Iacona, (unknown), (unknown), Mario Regazzi, G Bellinzona, Paolo Dionigi, (unknown)	2
15	Endogenous beta-endorphins in hypertension: Correlation with 24-hour ambulatory blood pressure 1996 ·Journal of the American College of Cardiology ·Luigina Guasti, (unknown), (unknown), Lorenzo Bianchi, Giovanni Gaudio, Mario Regazzi, Anna Maria Grandi, A Bertolini, (unknown), Achille Venco	42
16	COMBINED IMMUNOSUPPRESSIVE THERAPY WITH TACROLIMUS AND MYCOPHENOLATE MOFETIL FOR SMALL BOWEL TRANSPLANTATION IN PIGS1 1996 ·Transplantation ·M Alessiani, Marco Spada, Paolo Dionigi, Eloisa Arbustini, Mario Regazzi, (unknown), (unknown)	28
17	Once daily felodipine in preventing ergonovine-induced myocardial ischaemia in Prinzmetal's variant angina 1994 ·European Heart Journal ·M Chimienti, (unknown), Enrico Pusineri, Mario Regazzi, Luigi Inglese, Catherine Klersy, L. De Ambroggi	4
18	The need for pharmacokinetics protocols in special cases 1993 ·Pharmacological Research ·Mario Regazzi, R Rondanelli, Monica Calvi	3
19	FARMACOCINETICA DEL CEFTRIAXONE NEI PRIMI TRE MESI DI VITA 1992 ·R Rondanelli, Mario Regazzi, Mauro Stronati, Monica Calvi, G Lombardi, G Rondini	1
20	Bioavailability of diltiazem as a function of the administered dose 1991 ·Biopharmaceutics & Drug Disposition ·G. Bianchetti, Mario Regazzi, R Rondanelli, V. Ascalone, P. L. Morselli	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact